Jiapeng Li

5PUBLICATIONS
31CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 06, 2026
Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models.

Luca Lizzadro, Jiapeng Li, Taha Y Taha

|Apr 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy.

Tyler C Detomasi, Gilles Degotte, Sijie Huang

|May 01, 2024
Differential Bioactivation Profiles of Different GS-441524 Prodrugs in Cell and Mouse Models: ProTide Prodrugs with High Cell Permeability and Susceptibility to Cathepsin A Are More Efficient in Delivering Antiviral Active Metabolites to the Lung.

Jiapeng Li, Daniel Macedo de Melo Jorge, Weiwen Wang

|Oct 19, 2023
Cell-Dependent Activation of ProTide Prodrugs and Its Implications in Antiviral Studies.

Yueting Liu, Shuxin Sun, Jiapeng Li

|Oct 19, 2022
Tissue- and cell-expression of druggable host proteins provide insights into repurposing drugs for COVID-19.

Jiapeng Li, Yanling Xue, Xinwen Wang

Pageof 1

Frequent Collaborators

3 joint publications

Hao-Jie Zhu

2 joint publications

Charles S Craik

2 joint publications

Tyler C Detomasi

2 joint publications

Adam R Renslo